• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂类化疗导致的听觉功能早期变化:扩展高频听力测定法和诱发畸变产物耳声发射的应用

Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.

作者信息

Knight Kristin R, Kraemer Dale F, Winter Christiane, Neuwelt Edward A

机构信息

Department of Pediatric Audiology, Child Development and Rehabilitation Center, Portland, Oregon, USA.

出版信息

J Clin Oncol. 2007 Apr 1;25(10):1190-5. doi: 10.1200/JCO.2006.07.9723.

DOI:10.1200/JCO.2006.07.9723
PMID:17401008
Abstract

PURPOSE

The objective is to describe progressive changes in hearing and cochlear function in children and adolescents treated with platinum-based chemotherapy and to begin preliminary evaluation of the feasibility of extended high-frequency audiometry and distortion product otoacoustic emissions for ototoxicity monitoring in children.

PATIENTS AND METHODS

Baseline and serial measurement of conventional pure-tone audiometry (0.5 to 8 kHz) and evoked distortion product otoacoustic emissions (DPOAEs) were conducted for 32 patients age 8 months to 20 years who were treated with cisplatin and/or carboplatin chemotherapy. Seventeen children also had baseline and serial measurement of extended high-frequency (EHF) audiometry (9 to 16 kHz). Audiologic data were analyzed to determine the incidence of ototoxicity using the American Speech-Language-Hearing Association criteria, and the relationships between the different measures of ototoxicity.

RESULTS

Of the 32 children, 20 (62.5%) acquired bilateral ototoxicity in the conventional frequency range during chemotherapy treatment, and 26 (81.3%) had bilateral decreases in DPOAE amplitudes and dynamic range. Of the 17 children with EHF audiometry results, 16 (94.1%) had bilateral ototoxicity in the EHF range. Pilot data suggest that EHF thresholds and DPOAEs show ototoxic changes before hearing loss is detected by conventional audiometry.

CONCLUSION

EHF audiometry and DPOAEs have the potential to reveal earlier changes in auditory function than conventional frequency audiometry during platinum chemotherapy in children.

摘要

目的

本研究旨在描述接受铂类化疗的儿童和青少年听力及耳蜗功能的渐进性变化,并初步评估扩展高频听力测定法和畸变产物耳声发射用于儿童耳毒性监测的可行性。

患者与方法

对32例年龄在8个月至20岁之间接受顺铂和/或卡铂化疗的患者进行常规纯音听力测定(0.5至8kHz)及诱发畸变产物耳声发射(DPOAE)的基线和系列测量。17名儿童还进行了扩展高频(EHF)听力测定(9至16kHz)的基线和系列测量。分析听力学数据,根据美国言语-语言-听力协会标准确定耳毒性发生率,以及不同耳毒性测量指标之间的关系。

结果

32名儿童中,20名(62.5%)在化疗期间在常规频率范围内出现双侧耳毒性,26名(81.3%)的DPOAE振幅和动态范围出现双侧下降。在17名有EHF听力测定结果的儿童中,16名(94.1%)在EHF范围内出现双侧耳毒性。初步数据表明,在常规听力测定检测到听力损失之前,EHF阈值和DPOAE就显示出耳毒性变化。

结论

在儿童铂类化疗期间,EHF听力测定法和DPOAE比传统频率听力测定法有更早发现听觉功能变化的潜力。

相似文献

1
Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.铂类化疗导致的听觉功能早期变化:扩展高频听力测定法和诱发畸变产物耳声发射的应用
J Clin Oncol. 2007 Apr 1;25(10):1190-5. doi: 10.1200/JCO.2006.07.9723.
2
Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.影响畸变产物耳声发射对耳毒性听力损失敏感性的因素。
Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99.
3
Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.畸变产物耳声发射:一种用于筛查接受铂类衍生物治疗儿童听力损失的客观技术。
Int J Audiol. 2006 Jun;45(6):337-43. doi: 10.1080/14992020600582117.
4
[Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].[急性淋巴细胞白血病化疗期间儿童的耳声发射测量]
Otolaryngol Pol. 2006;60(3):415-20.
5
[Hearing evaluation in children during chemotherapy].[化疗期间儿童的听力评估]
Pol Merkur Lekarski. 2005 Sep;19(111):340-2.
6
Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.诱发耳声发射——一种监测顺铂所致儿童耳毒性的方法。
Int J Pediatr Otorhinolaryngol. 2001 May 31;59(1):47-57. doi: 10.1016/s0165-5876(01)00455-4.
7
The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.长春新碱治疗对瞬态诱发耳声发射和畸变产物耳声发射的影响。
Int J Pediatr Otorhinolaryngol. 2006 Jun;70(6):1003-8. doi: 10.1016/j.ijporl.2005.10.011. Epub 2005 Dec 15.
8
Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.儿童顺铂治疗后听力损失的左右不对称性——左耳受影响稍大,但差异显著。
Ear Hear. 2008 Dec;29(6):830-7. doi: 10.1097/AUD.0b013e31818005a4.
9
Ototoxic impact of cisplatin in pediatric oncology patients.顺铂对儿科肿瘤患者的耳毒性影响。
Laryngoscope. 1999 Nov;109(11):1806-14. doi: 10.1097/00005537-199911000-00016.
10
Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.畸变产物耳声发射测试对接受顺铂治疗的儿童有用。
Arch Med Res. 2003 May-Jun;34(3):205-8. doi: 10.1016/S0188-4409(03)00022-5.

引用本文的文献

1
Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system.儿童药物相关性听力损害:美国食品药品监督管理局不良事件报告系统的不成比例分析
Front Pharmacol. 2025 Jun 26;16:1532461. doi: 10.3389/fphar.2025.1532461. eCollection 2025.
2
Impact of Cisplatin on Hearing: Analysis Using PTA, High-Frequency Audiometry, DPOAE, and Speech-in-Noise Test.顺铂对听力的影响:使用纯音听力测试、高频听力测定、畸变产物耳声发射和噪声下言语测试的分析
OTO Open. 2025 Mar 5;9(1):e70097. doi: 10.1002/oto2.70097. eCollection 2025 Jan-Mar.
3
Noise-induced ribbon synapse loss in the mouse basal cochlear region does not reduce inner hair cell exocytosis.
噪声诱导的小鼠耳蜗基部区域带状突触损失不会降低内毛细胞的胞吐作用。
Front Cell Neurosci. 2025 Jan 7;18:1523978. doi: 10.3389/fncel.2024.1523978. eCollection 2024.
4
Optimizing a Classification Model to Evaluate Individual Susceptibility in Noise-Induced Hearing Loss: Cross-Sectional Study.优化分类模型以评估噪声性听力损失中的个体易感性:横断面研究
JMIR Public Health Surveill. 2024 Nov 14;10:e60373. doi: 10.2196/60373.
5
Prevalence of platinum-induced ototoxicity among patients suffering from hematological malignancies - a systematic review.血液系统恶性肿瘤患者中铂类药物所致耳毒性的患病率——一项系统评价
Contemp Oncol (Pozn). 2024;28(2):98-104. doi: 10.5114/wo.2024.141774. Epub 2024 Jul 26.
6
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.癌症治疗耳毒性管理全球实施模板路线图
Ear Hear. 2025;46(2):286-297. doi: 10.1097/AUD.0000000000001592. Epub 2024 Sep 12.
7
Central auditory system assessment in children and adolescents with cystic fibrosis: electrophysiology and central auditory processing.囊性纤维化儿童和青少年的中枢听觉系统评估:电生理学与中枢听觉处理
J Pediatr (Rio J). 2025 Jan-Feb;101(1):96-102. doi: 10.1016/j.jped.2024.06.013. Epub 2024 Sep 5.
8
Pulsed DPOAEs in serial measurements : Combined analysis paradigm of simultaneously occurring changes in hearing thresholds and DPOAEs.连续测量中的脉冲畸变产物耳声发射:听力阈值与畸变产物耳声发射同时发生变化的联合分析范式
HNO. 2024 Dec;72(Suppl 2):101-110. doi: 10.1007/s00106-024-01478-z. Epub 2024 Jul 3.
9
Remote Field Application of Digital Technology for Hearing Assessments in a Cohort of Pediatric Germ Cell Tumor Survivors.远程应用数字技术对小儿生殖细胞瘤肿瘤幸存者队列进行听力评估。
Cancer Epidemiol Biomarkers Prev. 2024 Sep 3;33(9):1177-1184. doi: 10.1158/1055-9965.EPI-24-0203.
10
[Pulsed DPOAEs in serial measurements : Combined analysis paradigm of simultaneously occurring changes in hearing thresholds and DPOAEs. German version].[连续测量中的脉冲畸变产物耳声发射:听力阈值和畸变产物耳声发射同时发生变化的联合分析范式。德文版]
HNO. 2024 Sep;72(9):639-648. doi: 10.1007/s00106-024-01477-0. Epub 2024 May 27.